Justin M. Oldham

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

<i>TOLLIP</i> , <i>MUC5B</i> , and the Response to <i>N</i> -Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis

Justin M. Oldham, Shwu‐Fan Ma, Fernando J. Martínez et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 359 citations

Life Sciences, Genetics, Immunology +17

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

Richard J. Allen, Beatriz Guillén‐Guío, Justin M. Oldham et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 341 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study

Richard J. Allen, Joanne Porte, Rebecca Braybrooke et al. · The Lancet Respiratory Medicine · 2017 · 300 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Characterisation of patients with interstitial pneumonia with autoimmune features

Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi et al. · European Respiratory Journal · 2016 · 278 citations · Full text

Medicine, Immunology, Internal Medicine +15